DAPACOOL-M is a combination medication that contains Dapagliflozin (10 mg) and Metformin (500 mg), designed to help manage type 2 diabetes. Dapagliflozin, an SGLT2 inhibitor, works by preventing the reabsorption of glucose in the kidneys, allowing excess glucose to be eliminated through urine. Metformin, a biguanide, reduces the amount of glucose produced by the liver and improves the body’s sensitivity to insulin. Together, these two components help to control blood sugar levels more effectively. This medication is typically prescribed alongside diet and exercise to improve glycemic control in adults with type 2 diabetes. However, it should be taken under the guidance of a healthcare professional to avoid potential side effects, such as low blood sugar, dehydration, and gastrointestinal discomfort. Regular monitoring of kidney function and blood sugar levels is essential for optimal results.